Elevated Beclin 1 expression is correlated with HIF-1α in predicting poor prognosis of nasopharyngeal carcinoma

Xiang‐Bo Wan, Xinjuan Fan, Ming‐Yuan Chen, +11

Autophagy

Aurora-A, a Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells

Zhong Guan, Xian-Ren Wang, Xiao‐Feng Zhu, +11

Cancer Research

Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes

Da-zhi Xu, Qi-rong Geng, Zi-Jie Long, +7

Annals of Surgical Oncology

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineD2 Resection Regardless +7

Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells

Xiang‐Bo Wan, Zi-Jie Long, Min Yan, +9

Carcinogenesis

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells

Zhi-Jie Hou, Xi Luo, Wei Zhang, +12

Oncotarget

Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation

Xiao-Na Pan, Jia-Jie Chen, Le-Xun Wang, +6

PLoS ONE

C-myc ExpressionMixed-phenotype Acute LeukemiaImmunologyCell DifferentiationTumor Biology +14

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells

Jia Rao, Duo-Rong Xu, Fei-Meng Zheng, +6

Journal of Translational Medicine

Prediction of competing endogenous RNA coexpression network as prognostic markers in AML

Jundan Wang, Hongsheng Zhou, Xi-Xiang Tu, +4

Aging

EngineeringGeneticsEndogenous RnasTranscriptomics TechnologyNormal Whole Blood +15

Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism

Ling-Ling Liu, Zi-Jie Long, Le-Xun Wang, +8

Molecular Cancer Research

A Novel Small-Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor–Initiating Cells and Overcomes Drug Resistance

Fei-Meng Zheng, Zi-Jie Long, Zhi-Jie Hou, +13

Molecular Cancer Therapeutics